Compile Data Set for Download or QSAR
Report error Found 265 Enz. Inhib. hit(s) with all data for entry = 1001
TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302203BDBM302203(US9598415, 115)
Affinity DataIC50: 67nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302265BDBM302265(US9598415, 177)
Affinity DataIC50: 73nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302289BDBM302289(US9598415, 201)
Affinity DataIC50: 75nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302297BDBM302297(US9598415, 209)
Affinity DataIC50: 75nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302293BDBM302293(US9598415, 205)
Affinity DataIC50: 80nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302191BDBM302191(US9598415, 103)
Affinity DataIC50: 82nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302280BDBM302280(US9598415, 192)
Affinity DataIC50: 83nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302279BDBM302279(US9598415, 191)
Affinity DataIC50: 86nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302247BDBM302247(US9598415, 159)
Affinity DataIC50: 91nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302245BDBM302245(US9598415, 157)
Affinity DataIC50: 92nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302233BDBM302233(US9598415, 145)
Affinity DataIC50: 95nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302212BDBM302212(US9598415, 124)
Affinity DataIC50: 97nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302281BDBM302281(US9598415, 193)
Affinity DataIC50: 99nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302185BDBM302185(US9598415, 97)
Affinity DataIC50: 101nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302246BDBM302246(US9598415, 158)
Affinity DataIC50: 106nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302202BDBM302202(US9598415, 114)
Affinity DataIC50: 107nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302201BDBM302201(US9598415, 113)
Affinity DataIC50: 108nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302181BDBM302181(US9598415, 93)
Affinity DataIC50: 110nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302189BDBM302189(US9598415, 101)
Affinity DataIC50: 115nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302214BDBM302214(US9598415, 126)
Affinity DataIC50: 119nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302287BDBM302287(US9598415, 199)
Affinity DataIC50: 120nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302277BDBM302277(US9598415, 189)
Affinity DataIC50: 120nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302312BDBM302312(US9598415, 224)
Affinity DataIC50: 120nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302300BDBM302300(US9598415, 212)
Affinity DataIC50: 120nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302182BDBM302182(US9598415, 94)
Affinity DataIC50: 125nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302296BDBM302296(US9598415, 208)
Affinity DataIC50: 125nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302270BDBM302270(US9598415, 182)
Affinity DataIC50: 130nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302209BDBM302209(US9598415, 121)
Affinity DataIC50: 130nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302278BDBM302278(US9598415, 190)
Affinity DataIC50: 130nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302188BDBM302188(US9598415, 100)
Affinity DataIC50: 130nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302231BDBM302231(BDBM302232 | US9598415, 143)
Affinity DataIC50: 134nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302211BDBM302211(US9598415, 123)
Affinity DataIC50: 135nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302311BDBM302311(US9598415, 223)
Affinity DataIC50: 135nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302257BDBM302257(US9598415, 169)
Affinity DataIC50: 145nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302210BDBM302210(US9598415, 122)
Affinity DataIC50: 150nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302274BDBM302274(US9598415, 186)
Affinity DataIC50: 150nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302298BDBM302298(US9598415, 210)
Affinity DataIC50: 150nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302321BDBM302321(US9598415, 233)
Affinity DataIC50: 155nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302345BDBM302345(US9598415, 257)
Affinity DataIC50: 155nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302314BDBM302314(US9598415, 226)
Affinity DataIC50: 155nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302205BDBM302205(US9598415, 117)
Affinity DataIC50: 155nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302301BDBM302301(US9598415, 213)
Affinity DataIC50: 155nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302284BDBM302284(US9598415, 196)
Affinity DataIC50: 157nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302253BDBM302253(US9598415, 165)
Affinity DataIC50: 157nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302339BDBM302339(US9598415, 251)
Affinity DataIC50: 158nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302305BDBM302305(US9598415, 217)
Affinity DataIC50: 160nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302226BDBM302226(US9598415, 138)
Affinity DataIC50: 160nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302216BDBM302216(US9598415, 128)
Affinity DataIC50: 160nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302251BDBM302251(US9598415, 163)
Affinity DataIC50: 160nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

TargetNuclear receptor ROR-gamma(Human)
Boehringer Ingelheim International

US Patent
LigandChemical structure of BindingDB Monomer ID 302231BDBM302231(BDBM302232 | US9598415, 143)
Affinity DataIC50: 162nMAssay Description:A nuclear receptor transactivation assay is performed to quantitate the ability of test compounds to inhibit RORγ transactivation of a luciferas...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
US Patent

Displayed 1 to 50 (of 265 total ) | Next | Last >>
Jump to: